Home
Cohance Lifesciences

七月 2026的Cohance Lifesciences市场份额分析

Streamline ADC development with Cohance’s integrated CRDMO services—covering antibody engineering, payload synthesis, and full regulatory compliance.

行业: 不适用

域cohance.com

成立年份--

员工1001 - 5000

年营收--

Cohance Lifesciences

Cohance Lifesciences（包含公司地区分支机构）

cohance.com

查看更多网站流量和参与度信息

Cohance Lifesciences热门域名的总访问量

了解Cohance Lifesciences市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

子公司明细

cohance.com9.6K

使用销售情报查看更多信息

Cohance Lifesciences热门域名的平均访问时长

分析Cohance Lifesciences参与度指标。

过去 3 个月的平均访问时长

子公司明细

cohance.com00:01:28

使用销售情报查看更多信息

Cohance Lifesciences热门域名的平均页面浏览量

了解Cohance Lifesciences如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

子公司明细

cohance.com1.69

使用销售情报查看更多信息

Cohance Lifesciences 排名靠前的竞争对手（按域名）

七月 2026的热门相似网站，按亲和力排名

sterlingpharmasolutions.com公司名称Sterling Pharma Solutions员工1001 - 5000总部美国, 威斯康星州, Germantown年营收$100M - $200M总访问量9.5K健康 > 生物科技及制药

Cohance Lifesciences 采用的主要技术

这些是排名前 Cohance Lifesciences 的顶级域名所使用的网站技术（按行业分列）

小部件 (5)

Twemoji

电子邮件服务 (3)

Sendgrid

付款和货币 (3)

PayPal

付费广告 (2)

Google Adsense

更多技术

10

查看全部

Cohance Lifesciences 的新闻与信号

借助 Similarweb 销售信号提醒，每当在目标受众之中出现新的机会或威胁时，您都会收到所识别出购买信号的每日更新。

新闻Himanshu Agarwal will leave Cohance Lifesciences Limited as chief financial officer and whole-time director on Sep 13th '26.Cohance Lifesciences Limited, formerly known as Suven Pharmaceuticals Limited, has announced the resignation of Himanshu Agarwal from his roles as chief financial officer and whole-time director.

新闻Cohance Lifesciences Limited has earnings of $2.05M.Net profit of Cohance Lifesciences declined 83.77% to Rs 19.55 crore in the quarter ended March 2026 as against Rs 120.43 crore during the previous quarter ended March 2025.

新闻Cohance Lifesciences Limited hired Umang Vohra as Executive Chairman and Group CEO on May 1st '26.Pharma veteran Umang Vohra to lead Advent-backed Cohance Lifesciences as chairman and CEO, succeeding Vivek Sharma amid efforts to revive growth and address regulatory challenges.